XML 86 R66.htm IDEA: XBRL DOCUMENT v3.23.2
Stock-based Compensation Expense - Schedule of Company's Stock Option Activity (Detail)
$ / shares in Units, shares in Thousands, $ in Thousands
6 Months Ended 12 Months Ended
Jun. 30, 2023
USD ($)
$ / shares
shares
Dec. 31, 2022
USD ($)
$ / shares
shares
Number of Shares Subject to Options    
Beginning balance (in shares) | shares 51,591  
Granted (in shares) | shares 0  
Cancelled, forfeited, and expired (in shares) | shares (432)  
Exercised (in shares) | shares (4,571)  
Ending balance (in shares) | shares 46,588 51,591
Exercisable (in shares) | shares 40,333  
Vested and expected to vest (in shares) | shares 46,588  
Weighted-Average Exercise Price (per Option)    
Beginning balance, weighted average exercise price (in dollars per share) | $ / shares $ 2.85  
Granted, weighted average exercise price (in dollars per share) | $ / shares 0  
Cancelled, forfeited, and expired, weighted average exercise price (in dollars per share) | $ / shares 4.73  
Exercised, weighted average exercise price (in dollars per share) | $ / shares 2.44  
Ending balance, weighted average exercise price (in dollars per share) | $ / shares 2.87 $ 2.85
Exercisable, weighted average exercise price (in dollars per share) | $ / shares 2.61  
Vested and expected to vest, weighted average exercise price (in dollars per share) | $ / shares $ 2.87  
Weighted-Average Remaining Contractual Term (Years) 5 years 6 months 14 days 6 years
Exercisable, weighted-average remaining contractual term 5 years 4 months 2 days  
Vested and expected to vest, weighted-average remaining contractual term 5 years 6 months 14 days  
Aggregate Intrinsic Value | $ $ 1,743,596 $ 1,321,183
Exercisable, aggregate intrinsic value | $ 1,519,987  
Vested and expected to vest, aggregate intrinsic value | $ $ 1,743,596